Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Ost, P; Reynders, D; Decaestecker, K; Fonteyne, V; Lumen, N; De Bruycker, A; Lambert, B; Delrue, L; Bultijnck, R; Claeys, T; Goetghebeur, E; Villeirs, G; De Man, K; Ameye, F; Billiet, I; Joniau, S; Vanhaverbeke, F; De Meerleer, G

Ost, P (reprint author), Ghent Univ Hosp, Dept Radiotherapy, De Pintelaan 185, B-9000 Ghent, Belgium.

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (5): 446

Abstract

PurposeRetrospective studies suggest that metastasis-directed therapy (MDT) for oligorecurrent prostate cancer (PCa) improves progression-free surviva......

Full Text Link